Lupin Limited

Lupin Limited, a pharmaceutical company based in Mumbai, India, is engaged in the development, production, marketing, and sale of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company offers formulations for various therapeutic areas including cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. Additionally, Lupin Limited is involved in the provision of biosimilar and over-the-counter products, specialty products, and drug discovery and development programs in the fields of oncology, immunology, and metabolic disorders. The company's extensive network comprises 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. Lupin Limited operates not only in India but also in several other countries such as the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally known as Lupin Chemicals Limited, the company changed its name to Lupin Limited in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited has established itself as a prominent player in the pharmaceutical industry.